Sutro Biopharma (STRO) Insider Trading & Ownership $1.30 +0.40 (+44.44%) As of 04:00 PM Eastern Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Sutro Biopharma (NASDAQ:STRO) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage5.90%Number OfInsiders Buying(Last 3 Years)0Number OfInsiders Selling(Last 3 Years)2Amount OfInsider Selling(Last 3 Years)$186,894.55 Get STRO Insider Trade Alerts Want to know when executives and insiders are buying or selling Sutro Biopharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address STRO Insider Buying and Selling by Quarter Sutro Biopharma Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails1/29/2024Nicki VasquezInsiderSell12,185$5.00$60,925.00 8/28/2023Brunilda ShtyllaInsiderSell15,428$4.71$72,665.88 8/25/2023Brunilda ShtyllaInsiderSell11,613$4.59$53,303.67 (Data available from 1/1/2013 forward) STRO Insider Trading Activity - Frequently Asked Questions Who is on Sutro Biopharma's Insider Roster? The list of insiders at Sutro Biopharma includes Brunilda Shtylla, and Nicki Vasquez. Learn more on insiders at STRO. What percentage of Sutro Biopharma stock is owned by insiders? 5.90% of Sutro Biopharma stock is owned by insiders. Learn more on STRO's insider holdings. Which Sutro Biopharma insiders have been selling company stock? The following insiders have sold STRO shares in the last 24 months: Brunilda Shtylla ($125,969.55), and Nicki Vasquez ($60,925.00). How much insider selling is happening at Sutro Biopharma? Insiders have sold a total of 39,226 Sutro Biopharma shares in the last 24 months for a total of $186,894.55 sold. Sutro Biopharma Key ExecutivesMr. William J. Newell J.D. (Age 66)CEO & Director Compensation: $1.06MDr. Hans-Peter Gerber Ph.D. (Age 61)Chief Scientific Officer Compensation: $575.83kDr. Anne Elizabeth Borgman-Hagey M.D. (Age 56)Chief Medical Officer Compensation: $848.98kMs. Jane Chung R.Ph. (Age 53)President & COO Compensation: $934.64kDr. James R. Swartz DScPh.D., Sc.D., FounderMr. Edward C. Albini M.B.A (Age 66)CFO & Secretary Compensation: $596.4kDr. Venkatesh Srinivasan Ph.d. (Age 62)Chief Technical Operations Officer Mr. David Pauling J.D.M.A., General CounselMs. Linda A. Fitzpatrick (Age 67)Chief People & Communications Officer Compensation: $595.79kDr. Nicki Vasquez Ph.D. (Age 61)Chief Portfolio Strategy & Alliance Officer More Insider Trading Tools from MarketBeat Related Companies Ocugen Insider Selling Amarin Insider Selling biote Insider Selling Cardiff Oncology Insider Selling Gossamer Bio Insider Selling Design Therapeutics Insider Selling Tevogen Bio Insider Selling TuHURA Biosciences Insider Selling LifeVantage Insider Selling Voyager Therapeutics Insider Selling Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Insider Buying in This Stock Reiterates Analysts Bullish OutlookBeware of BigBear.ai: Insiders Are Selling—Should You?XPO Buying $50 Million of Its Own Stock: Here's Why Top 3 Large Cap Stocks Insiders Bought in Q1: Buy, Sell, or HoldJoby Aviation: Operational Momentum vs. Market Sentiment This page (NASDAQ:STRO) was last updated on 4/24/2025 by MarketBeat.com Staff From Our PartnersMost gold “analysts” aren’t really gold analysts… [watch out]People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredTrump’s Bitcoin Reserve is No Accident…Bryce Paul believes this is the #1 coin to buy right now The catalyst behind this surge is a massive new b...Crypto 101 Media | SponsoredJames Altucher: Do not invest in AI unless…I made millions during the crypto boom. Many “experts” are now saying… Artificial Intelligence opportuni...Paradigm Press | SponsoredThe Exact July Date the AI Correction Will End?AI stocks have cooled off—but Jeff Brown, the tech expert who picked Nvidia before it soared 222x, says one da...Brownstone Research | SponsoredThis Is The Moment You Betray Trump (Or Prove Them Wrong)They said you wouldn’t last—that Bidenflation, Wall Street selloffs, and DEI funds would break your loyalty to...Colonial Metals | SponsoredTrump’s treachery Forget what the media tells you. Trump’s inner circle may be pushing a financial reset that mirrors moves from...Porter & Company | SponsoredMusk’s AI Masterplan – Our #1 AI Stock to Buy NowDid Elon Musk just set the stage for the next AI stock explosion? One 30-year Wall Street veteran thinks so...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sutro Biopharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sutro Biopharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.